Herein, we conducted an in‐depth pan‐cancer investigation of STEAP3's role in cancer prognosis and immunology, demonstrating that STEAP3 could potentially serve as a predictive biological marker as well as a predictor of the responsiveness to immunotherapy in a variety of malignancies. This evidence concerns the gene STEAP3 and cancer.